Loneliness, Distress Tolerance Play Key Roles in Depression During COVID-19 Pandemic
More than half (61.5%) of respondents reported having high loneliness, as assessed by the 3-item version of the UCLA Loneliness Scale Short Form.
More than half (61.5%) of respondents reported having high loneliness, as assessed by the 3-item version of the UCLA Loneliness Scale Short Form.
Combination therapy in the same visit is an effective and safe treatment option for
atrophic acne scars in patients with various skin types.
Non-ablative fractional erbium glass and ablative fractional erbium YAG laser therapies seem promising in the short term, with minimal adverse effects.
The EADV Task Force on Quality of Life and Patient Oriented Outcomes released a position statement on QoL issues in dermatology patients during COVID-19.
Findings from many meta-analyses do not reflect the real-world safety of biologic agents for psoriasis.
Secukinumab showed sustained and clinically meaningful efficacy, improvement in QoL for up to 2.5 years in patients with psoriatic nail involvement.
A study identifies the most common skin disorders in patients diagnosed with COVID-19 infection before and during the pandemic.
Dupilumab provides long-term control of AD and prevents disease flares, which may help reduce the need for escalation and/or intensification of therapy.
Varied clinical presentations of scabies and advances in diagnosis and management are reviewed.
The sequence of AD progression from acute to chronic stages, with progressively heightened inflammatory response for all major immune axes, has been delineated.